Biospecimen and Biomarker Specialist Adds
Next-Generation Capability of OLINK Explore HT
HUNTSVILLE, Ala., Oct. 5, 2023
/PRNewswire/ -- Discovery Life Sciences (Discovery), the
Biospecimen and Biomarker Specialists, today announced it has
expanded its high-throughput proteomics services with the addition
of Olink Explore HT. A next-generation proteomics solution, the new
Olink Explore HT platform achieves greater precision and
speed—enhancing Discovery's position as a comprehensive provider of
proteomics and multi-omic services.
The Olink platform delivers exceptional sensitivity and
specificity for protein biomarker measurement. Olink Explore HT is
the company's latest solution for high-throughput proteomics,
allowing scientists to accurately measure over 5,300 proteins using
only two microliters of sample.
The addition of Olink Explore HT to Discovery's research and
clinical services will significantly impact three core areas:
- Deepening biological insights for a nuanced understanding of
disease mechanisms.
- Enhancing biomarker discovery for pre-clinical development and
clinical trials.
- Powering high-throughput proteomic analysis for
population-scale health studies.
Discovery's Proteome Center provides the most current
technologies in mass spectrometry, plasma proteomics, and the
entire spectrum of Olink solutions, including Olink Explore HT,
Explore 3072, Target, Focus, and Flex―each designed to suit a
variety of scientific objectives. The Center possesses the
scientific expertise to maximize the capability of these
state-of-the-art technologies to measure thousands of proteins from
only microliters of complex samples, including plasma and serum, in
a single experiment.
"We are extremely excited to see the entire portfolio of Olink
proteomics solutions being adopted by Discovery Life Sciences, a
global leader in proteomics applications," said Mike Irwin, Olink VP of Sales and Marketing. "As
part of a worldwide network of service providers and with their
biospecimen specialty and state-of-the-art Olink proteomics
solutions implementation, Discovery is well-positioned to
contribute to a safer and healthier world."
"Discovery continues to stay ahead of the proteomics
revolution," said Glenn Bilawsky,
Discovery CEO. "By integrating Olink Explore HT with our access to
the world's largest biospecimen inventory and the advanced robotic
automation of our Proteome Center, we significantly enhance the
quality, speed, and efficiency of protein biomarker analyses. We
can provide target specimens for analysis and derive more data from
smaller samples in less time than our competitors. Our continued
investment in innovative technologies like Olink Explore HT further
empowers us to fulfill our mission of helping our clients advance
new therapies and diagnostics to patients and their
caregivers."
To learn more about Discovery's proteomic services capabilities,
please visit www.dls.com/biomarker-services/proteomics.
About Discovery Life Sciences
Discovery Life Sciences is the company of Biospecimen and
Biomarker Specialists. We combine a comprehensive commercial
biospecimen inventory and procurement network with outstanding
multi-omic biomarker service laboratories. Our offerings include
genomic, tissue biomarker, proteomic, and cell-based services,
accelerating the development of new therapies supported by
biomarker and companion diagnostic programs for cancer, infectious
disease, and other rare and complex conditions.
Through AllCells, our cell and gene therapy division, we
maintain a substantial recallable donor pool, supplying Research
Use Only (RUO) and clinical-grade fresh and cryopreserved human
cellular materials to support cell and gene therapy programs at any
phase of development and scale.
Motivated by leading scientific expertise and innovative
application of current technologies, the Discovery team
collaborates with customers to rapidly overcome obstacles and
achieve results, aiding in making critical research and development
decisions with unparalleled speed. We are Science at your Service!
For more information, visit www.dls.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/discovery-life-sciences-expands-high-throughput-proteomics-services-301947757.html
SOURCE Discovery Life Sciences
